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Abstract: Skeletal muscle aging manifests as a decline in muscle quantity and quality that
accelerates with aging, increasing the risk of sarcopenia. Sarcopenia is characterized by a
loss of muscle strength and mass, and contributes to adverse health outcomes in older adults.
Intervention studies have shown that sarcopenia may be treated by higher protein intake in
combination with resistance exercise (RE). In comparison, less is known about the role of
whole protein-containing foods in preventing or treating sarcopenia. Liquid milk contains
multiple nutrients and bioactive components that may be beneficial for muscle, including
proteins for muscle anabolism that, alone or with RE, may have myoprotective properties.
However, there is a lack of evidence about the role of milk and its effects on muscle aging.
This narrative review considers evidence from three observational and eight intervention
studies that used milk or fortified milk, with or without exercise, as an intervention to
promote muscle health and function in older adults (aged 50–99 years). The observational
studies showed no association between higher habitual milk consumption and muscle-related
outcomes. The results of intervention studies using fortified milk in relation to elements of
sarcopenia were also negative, with further inconclusive results from the studies using a
combination of (fortified) milk and exercise. Although milk contains nutrients that may be
myoprotective, current evidence does not show beneficial effects of milk on muscle health in
older adults. This could be due to high habitual protein intakes (>1.0 g/kg BW/d) in study
participants, differences in the type of milk (low-fat vs whole) and timing of milk consump-
tion, length of interventions, as well as differences in the sarcopenia status of participants in
trials. Adequately powered intervention studies of individuals likely to benefit are needed to
test the effectiveness of a whole food approach, including milk, for healthy muscle aging.
Keywords: sarcopenia, muscle health, whole foods, milk, myoprotective properties, older
adults
Introduction
The natural loss of skeletal muscle mass after the age of 30 accelerates in later life.1
There are even steeper losses in muscle strength and power,1,2 adversely affecting
physical functioning in older adults and increasing the risk of sarcopenia.
Sarcopenia—loss of skeletal muscle strength and mass1,3—is associated with
adverse health outcomes in older adults, including frailty, falls, disability, hospita-
lization, and earlier death.3–8 Sarcopenia has a complex pathogenesis and no
pharmacological treatments have yet been shown to be effective. Several cellular
processes including low-grade inflammation, oxidative stress, anabolic resistance,
motor unit denervation and mitochondrial dysfunction are thought to contribute to
reduced myofibre quantity and quality with aging.9,10 Current recommendations for
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treatment and prevention of sarcopenia focus on modifi-
able lifestyle factors such as diet and nutrition in combina-
tion with physical exercise9,11 mostly using a single
nutrient approach.11–16 Using a whole food or whole diet
approach, accounting for the combined effect of multiple
food components on muscle has emerged as a treatment
paradigm only recently.17 For example, a protein intake
higher than the recommended daily allowance of 0.8 g/kg
body weight/day (g/kg BW/d) has been debated as optimal
for maintaining and regaining muscle mass and better
physical performance in healthy older adults11–15—prefer-
ably by consuming high-quality, protein-rich foods distrib-
uted across meals.16 Dietary protein sources and isolated
protein supplements such as whey that have a higher
content of branched-chain amino acids (BCAA) (eg,
13.4% leucine in whey)—an established regulator of mus-
cle protein anabolism18—have been regarded as superior
for muscle mass and performance in younger and older
adults.19,20 However, less is known about how whole
protein-containing foods, that are also rich in other essen-
tial nutrients and bioactive components, may be myopro-
tective and influence muscle health and function in older
adults.21 Protein-containing foods that are affordable and
easy to prepare also need to be acceptable to older adults
and a sustainable dietary source for the environment.22,23
Bovine milk is an attractive candidate whole food for
evaluation because of its nutrient composition and poten-
tial benefits for human health.
The purpose of this narrative review is threefold: (1) to
discuss the potential myoprotective properties of liquid
milk; (2) to summarize and discuss findings from observa-
tional and intervention studies of the effects of milk, with
or without exercise, in relation to muscle-health outcomes
and sarcopenia in older adults, and (3) to discuss the
evidence needed to inform future interventions with
whole foods, including dairy foods, for healthy muscle
aging.
Potential Myoprotective and Health
Benefits of Liquid Milk
Nutritional Composition of Milk
Milk and milk products (eg, yogurts and cheeses) are exam-
ples of whole foods dense in nutrients that may have poten-
tial for improving muscle mass21 and performance,24 and
therefore increasing consumption could be a preventive
strategy for sarcopenia.25 Liquid milk, an important part
of a healthy diet for over six billion people,26 contains a
range of nutrients27 and bioactive components28 that are
potentially valuable for human health.26 On average,
whole (bovine) milk provides high-quality proteins (20%
of whey and 80% of caseins), minerals (eg, calcium, phos-
phorus, magnesium, iodine), vitamins (eg, fat-soluble A and
E and water-soluble B vitamins), carbohydrates (lactose and
oligosaccharides), and fats—a mixture of 70% saturated
(SFA), and 30% of mono- (MUFA) and polyunsaturated
fatty acids (PUFA).26
Specifically, in addition to its average protein content of
32 g/L, daily consumption of 500 mL of whole milk would
make a significant contribution to other daily nutrient intakes;
approximating 15–20% of the dietary recommended intake for
vitamin A (280 µg/L); 60–80% for riboflavin (1.83 mg/L);
90% for vitamin B12; 40–50% for calcium (1.1 g/L); 18–25%
for zinc (4 mg/L); 30% for selenium (37 µg/L); 12–16% for
magnesium (100 mg/L) and 50% of the requirements for
iodine (for an average of 160 µg/L) in US adults.26,29
Beyond protein, milk also provides bioactive peptides,
which have several physiological effects, including antihy-
pertensive, antithrombotic, antimicrobial and immunomodu-
latory effects.28,30 Briefly, α- (13 g/L) and β-caseins (9.3 g/L)
are precursors of several peptides, including those involved
in the inhibition of angiotensin-converting enzyme (ACE),31
whilst β-lactoglobulin (3.2 g/L) is recognized as a potential
anti-oxidant and retinol carrier, and immunoglobulins (A, M,
and G; 0.7 g/L) and lactoferrin (0.1g/L) have been linked to
immunoprotection (reviewed in Mills et al).28 In addition,
milk contains essential fatty acids such as PUFA (2.3% of
total FA or 2 g/L)27,28—although in low amounts—that can
be manipulated by different farming practices (animal diet,
management and season).32 Specifically, milk PUFA include
linoleic acid (LA 18:2 n–6; 18 g/kg of total FA), α-linoleic
(ALA 18:3 n-3; 6.9 g/kg of total FA), and long-chain n-3 FA
(LC n-3; 1.8 g/kg of total FA) that are metabolically active
and have specific functions in cell membranes.27,32
In summary, milk is a complex food that contains a
number of nutrients and other biologically active compo-
nents that are beneficial for human health. Milk is also an
established part of the diet for many older adults who are,
in general, higher consumers compared with younger
adults,33 and thus may provide them with nutrients and
bioactive components relevant for aging muscle.
Milk and Human Health
Epidemiological studies have reported associations
between higher milk/dairy intake, and better health and
functioning across the life course. For example, higher
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milk/dairy intake has been associated with better bone
mineralization in early life, and slower age-related bone
loss and reduced risk of hip fractures in later life;34–37
favorable or neutral associations with different cardiovas-
cular clinical outcomes (coronary artery disease, stroke,
type 2 diabetes, hypertension, and metabolic syndrome);38
beneficial associations with body composition,39 and
reduced risk of obesity40 and colorectal cancers in middle-
aged and older adults.41
Higher intake of milk was positively associated with
performance in the 20-m endurance test and negatively
associated with BMI in children aged 9–12 years, thought
to be mediated through greater dietary intakes of milk-
derived vitamin B2 and B12, which contributed to higher
cardio-respiratory fitness.42 In addition, intervention stu-
dies with fat-free and skimmed milk in combination with
RE in young adults and athletes have shown higher lean
muscle, fat mass loss, increased muscle strength,43,44 and
greater muscle protein synthesis (MPS),45 compared with
an isocaloric carbohydrate or soy-based drink. Ingestion of
milk (including chocolate milk) post-exercise has been
shown to attenuate exercise-induced muscle damage and
soreness, increase MPS, and rehydrate muscles in athletes
and young, active adults as effectively or even better that
any other commercially available recovery drink.46,47
Taken together, studies in young adults highlight the
potential health benefits of milk for muscle beyond ana-
bolic effects of its main protein constituents (whey and
caseins). However, little is known about how milk con-
sumption may affect muscle health and function in older
adults who are at high risk of sarcopenia and associated
adverse health outcomes.
Potential Mechanisms of Milk Effects on
Skeletal Muscle Health in Older Adults
A whole food approach in investigating the relationship
between protein-rich foods and muscle with aging posits a
number of myoprotective properties of unfortified milk,
beyond those that are proanabolic (ie, MPS-promoting).
These properties include anti-oxidative, anti-inflammatory,
and immunomodulatory effects (Figure 1).
Proanabolic Effect of Milk-Based Proteins: An
Example of Whey
Whey proteins in milk (such as β-lactoglobulin, α-lactal-
bumin, lactoferrin, and immunoglobulins) are character-
ized as a fast-digestible proteins giving rise to a high
concentration of essential amino acids (EAA) available
to support MPS post-digestion.12,27,48 Whey is a rich
source of the BCAA leucine (13.4% or 122 mg/g of
whey),30 which appears to be the most important EAA to
stimulate MPS in skeletal muscle18,48 through the rapamy-
cin (mTOR) pathway—a key regulator of human MPS in
response to increased EAA.49 The ability of leucine to
induce MPS has been explained by the “leucine threshold”
hypothesis and demonstrated in numerous human and ani-
mal trials (discussed in Devries et al).48 The hypothesis
posits that, in order to increase MPS after protein inges-
tion, the intracellular leucine concentration in myofibres
has to reach a desired level, which can be altered by other
stimuli, lowered by RE and increased by aging and seden-
tary lifestyle.48 For younger active men, the amount of
leucine needed to exceed the threshold and induce max-
imal MPS has been estimated to be 1.7 to 2.4 g provided in
20 g of high-quality protein, or in a per meal feeding dose
of 0.25 g protein/kg BW.50 For older adults, a higher
protein (leucine) intake for MPS has been suggested
because of anabolic resistance, and estimated to be 0.38
g/kg BW per meal.50 Numerous trials have shown a syner-
gistic effect of protein supplementation and RE when
protein ingestion follows a bout of RE, resulting in a
greater MPS compared with either stimulus alone (dis-
cussed in Devries et al).48 The whey (leucine) potential
to augment the anabolic effect of prolonged exercise
(>6 weeks) has been show for fat-free mass and one
repetition maximum (1-RM) leg press strength in a meta-
analysis that included six trials with older adults (aged
>50 years), a mean difference of 0.91 kg (p<0.0001) and
20.7 kg (p<0.005), respectively.51
Anti-oxidative, Anti-inflammatory, and
Immunomodulatory Properties of Milk Bioactive
Components
Several lines of research have shown that oxidative stress
and accumulation of reactive oxygen and nitrogen species
(ROS/RNS) in aging muscle impairs cellular homeostasis
and causes damage to key cell biomolecules (ie, proteins,
nucleic acids, lipids) and organelles52 contributing to
sarcopenia.9,10 A number of milk-derived bioactive pep-
tides (eg, β-lactoglobulin, lactoferrin),26–28,30 lipids and
fatty acids (eg, α-linoleic acid, the milk fat globule mem-
brane (MFGM) lipids and glycoproteins),26–28,53 and
minerals (eg, selenium, zinc) have been shown to have
anti-oxidative properties, which may add to the exogenous
antioxidant capacity of a balanced diet in neutralizing
ROS/RNS in myofibres. An anti-inflammatory effect is
Dovepress Granic et al
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the other bioactivity associated with milk constituents
(such as casein-derived bioactive peptides26,28 and n-3
PUFA) that may ameliorate inflammaging in muscle by
reducing cytokine load (eg, by decreasing levels of inter-
leukin 6 and 8 (IL-6 and IL-8) and tumor necrosis factor α
(TNF-α)).52 Inflammaging, the age-related chronic low-
grade inflammation characterized by higher concentrations
of pro-inflammatory mediators in serum and plasma, have
been linked to worse age-related pathologies9,10,54 and loss
of muscle mass and function.52,54 The n-3 PUFAs have
been proposed as a therapeutic agent for sarcopenia
because of their anti-inflammatory properties, anabolic
effect on skeletal muscle metabolism through mTOR acti-
vation, and reduction of insulin resistance.55 Although
investigations about the role of immune function in sarco-
penia lag behind other mechanistic studies, a decline of
innate immunity and its link with inflammaging has been
postulated in the pathogenesis of frailty and sarcopenia.56
Milk contains several immunomodulatory components (eg,
immunoglobulins, lactoferrin, α-lactalbumin)28 that may
act against cytokine-derived inflammation.
Furthermore, antihypertensive bioactive peptides found
in milk (eg, lactopeptides α-lactorphin and β-lactorphin
released from α-lactalbumin and β-lactoglobulin, respec-
tively) acting as ACE inhibitors28,31 may have potential as
a therapy for sarcopenia. ACE inhibitors (including those
that are milk-derived) may have multiple beneficial effects
on aging muscle,57 including the ability to reduce inflam-
mation, promote glucose uptake, and improve endothelial
function, angiogenesis and muscle blood flow.9,58
Synergistic and cumulative actions of milk-derived bioac-
tive components through these pathways may enhance
milk’s proanabolic effects post-exercise. However, evi-
dence is very limited and further research is needed to
understand the bioactive potential of milk for healthy
muscle aging. For example, future studies with older
Figure 1 Hypothesized myoprotective properties of nutrients in liquid milk.
Notes: Hypothesized health effects and function of milk nutrients and bioactive components on muscle may include energy, minerals and vitamin delivery, anabolic, anti-oxidative,
anti-inflammatory, and immunomodulatory pathways. Common pathways across the nutrients and non-nutrients are presented in the outer circle in white. ©Newcastle University.
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License https://creativecommons.org/licenses/by-nc-sa/3.0/.
Abbreviations: EAA, essential amino acids; MFGM, milk fat globule membrane; MPS, muscle protein synthesis.
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adults are needed to determine whether the presence of fats
(fatty acids) in whole milk enhances absorption of EAA
for MPS as observed in young athletes post-exercise,59 and
in combination with other myoprotective effects, including
the delivery of fat-soluble vitamins (eg, vitamin A, E, K)
that may be relevant for muscle health.
In summary, myoprotective effects of milk may work
through anabolic, anti-oxidative, anti-inflammatory and
immunomodulatory pathways associated with the main
nutrients in milk, including proteins, fats, vitamins and
minerals, and milk sugars (Figure 1). Their synergistic
and cumulative action may provide myoprotection beyond
proanabolic effects of milk proteins such as whey.
Evidence About the Role of Liquid
Milk in Skeletal Muscle with Ageing
Materials and Methods
For the narrative summary of evidence, systematic
searches of four electronic databases (MEDLINE,
Embase, Web of Science, CENTRAL) were conducted
independently by two researchers (LD, CH) for articles
published in English in the period from January 2010 until
June 2019. Observational and intervention studies were
searched using the following search terms and their com-
bination: “liquid milk”, “fluid milk”, “whole milk”,
“skimmed milk”, ‘milk-based drinks’, “fortified milk”,
“grip strength”, “physical performance”, “muscle mass“’,
“sarcopenia”, “older adults”, “elderly”, “intervention”,
“randomized controlled trial” and “cohort study”. Only
full-text articles with clearly described populations (eg,
community-dwelling older adults aged ≥65 years), expo-
sure and study arms (milk, fortified milk with or without
exercise; excluding reconstituted milk-based drinks from
powder or those insufficiently defined), study duration,
outcome (muscle mass, strength, power, physical perfor-
mance, sarcopenia), and power to support the conclusions
were critically evaluated (CH, LD) and selected for the
review. Relevant information from the selected articles
were extracted independently (CH, LD) and compared,
including study name, duration, sex and age of partici-
pants, sample size, exposure, outcomes, main findings,
and study limitations.
Results
Evidence from Observational Studies
Three observational studies (two articles) assessed evidence
about the association between liquid milk consumption and
muscle-related outcomes (Table 1). 60,61 One study aimed to
address the association between habitual consumption and
physical performance in old age using data from the Boyd
Orr study and the Caerphilly Prospective Study (CaPS).60 In
the Boyd Orr study, a week-long dietary household inventory
was completed by families, involving 4999 children (aged
0–19). Sixty-five years later, 405 men and women (mean age
70.7 years) took part in a detailed clinical examination invol-
ving physical performance tests. Individual consumption of
whole milk (grams/day) was estimated from the household
inventory. A higher childhood milk intake was associated
with 5% faster walking times assessed by Timed Up-and-Go
(TUG) test, and better balance in later life. However, the
study found no association between adult milk intake and
walking time, and a negative association between higher
milk consumption and balance (Table 1). Contrasting results
were observed in the CaPS study of 1195 men—a unit
increase in whole milk intake (half a pint milk/day) at dietary
assessment (age range: 59–73 years) was associated with
21% lower risk of poor balance at follow-up (age range:
66–86 years). The Boyd Orr findings suggest ensuring ade-
quate milk consumption is a potentially modifiable health
behavior in early years, to enhance physical performance in
old age.
In the Helsinki Birth Cohort Study, a prospective study
of over 1000 older adults (mean age 61 years at baseline)
that assessed the association between a healthy Nordic
Diet (ND) and physical performance at 10-year follow-
up, low consumption of low-fat milk at baseline was
independently associated with better overall Senior
Fitness Test score in men but not in women.61 Low-fat
milk (skimmed and milk with fat content <2%) consump-
tion, a favorable component of ND score, was estimated
from food frequency questionnaires and assigned a value
of 0–3 according to ascending sex-specific quartiles. The
findings may have limited generalizability because those
who were assessed at follow-up had healthier diets at
baseline, were younger and more highly educated, and
thus may not be representative of the general older adult
population in Helsinki. In addition, uncontrolled con-
founding (eg, change in diet over time) and sex-specific
differences in food choices (including milk) may have
biased the results.
In summary, observational research investigating the
association between liquid milk consumption, muscle
strength and physical performance in older adults is
scarce. We found only three studies focussed on older
adults, and none of them have investigated the role of
Dovepress Granic et al
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milk specifically in individuals with sarcopenia. Whilst
higher childhood whole milk consumption might foster
better physical performance and balance in later life, the
results for the role of milk in muscle health and function in
older adults were mixed, warranting further prospective
research in older cohorts.
Evidence from Liquid Milk and Fortified
Milk Intervention Studies with and
without Exercise
Main Characteristic of the Studies: Participants,
Intervention and Outcomes
In a recent meta-analysis of 14 randomized controlled
trials (RCT) that investigated the efficacy of dairy protein
supplementation on muscle strength, mass, and function in
middle-aged and older adults (with or without sarcopenia),
an increase in appendicular muscle mass (AMM) was
observed with higher dairy protein intake, whilst the
results for physical functioning were inconclusive.21
However, the evidence was based mainly on isolated
dairy-source proteins with only two trials using whole
foods (cheese).
To date, only a limited number of intervention studies
have evaluated the effects of liquid milk or fortified milk
(ie, with additional nutrients) on measures of muscle
health and physical performance in older adults. These
studies typically involve either: (1) milk supplementation
alone or (2) a combination of milk supplementation and
exercise training and are summarized in Table 2. Briefly,
we identified eight intervention studies62–69 (two with milk
supplementation alone62,63) and six with combined supple-
mentation and exercise64–69 involving healthy (three
studies65,67,68) or (pre)sarcopenic community-dwelling
older adults (two studies63,66), and older adults with phy-
sical impairments living in residential care facilities (three
studies63,64,69). Seven were RCTs;63–69 three included only
men.65–67 The studies enrolled older adults aged 50 to
99 years in samples ranging from 26 to 177 participants,
with interventions lasting from 12 weeks to 18 months.
Only one used fortified whole milk,62 and the remainder
used reduced fat milk/low fat milk (≤1.6% fat)63–69 of
which two used chocolate milk.66,67 Milk was fortified
with several nutrients in all but one study,67 including
protein,63,64,66,68,69 calcium and vitamin D62,65 and
EAA.66 The amount of protein ingested via fortified milk
varied from 10.5 g68 to 40 g63 consumed either every day
or after exercise on the training days over the study period.
Muscle health and function-related outcomes also varied
considerably across the studies, and included the measures
of muscle mass (eg, total muscle mass, lean muscle mass,
skeletal muscle index (SMI)),63–66,68 strength (eg, leg
press, chest press, grip strength),62,63,65,67,68 and physical
performance (eg, TUG, stair climb, chair rises, gait speed,
balance).62,63,65,66,68,69
Interventions Involving Fortified Milk: Evidence
A study of 107 care residents (mean age 79.9±10.1 years)
found no association between fortified whole milk intake,
TUG and grip strength following a six-month intervention
designed to promote milk consumption.62 There was a
trend for slower TUG time (mean (SD) −2.56 (15.6),
p=0.07) over the study period, but no difference in GS
pre- and post-intervention (17.4±0.9 kg vs 17.6±0.8 kg,
p=0.7). However, the supply of milk to residents’ diets
(added to drinks and cereal) was left to the discretion of
the nursing staff, aiming for a mean intake of 210 mL/day
per resident. The median consumption was 160 mL/day
and estimated based on self-reports. Consistent with this
finding, a study of 50 community-dwelling older adults
with reduced physical functioning, who were provided
with 2x400 mL of protein-enriched milk (2x20 g protein)
each day for 12 weeks, also showed no improvements in
muscle mass, strength or functional performance when
compared with a control group consuming an isocaloric,
non-nitrogenous control drink.63 Specifically, although
chest press improved significantly in the protein (1.3 kg
(0.1–2.5), p=0.03) and control group (1.5 kg (0.0–3.0),
p=0.048), no difference between the groups (p=0.9) were
observed. Furthermore, no significant change in leg press
(p=0.9) or muscle mass (p=0.54), or the physical perfor-
mance tests (ie, chair rise, stair climb, and GS test; p>0.05
for all tests) were observed between the groups after the
12-week intervention. Importantly, in both studies baseline
protein intake was >0.8 g/kg BW/d, which would be
expected to have affected the potential impact of (fortified)
milk on muscle mass and function.
Interventions Involving Fortified Milk and Exercise:
Evidence
In the longest duration intervention to date, an 18-month
intervention, Kukuljan et al65 found no beneficial effect of
fortified milk consumption (2x200 mL of reduced fat UHT
milk consumed daily supplemented with Ca and vitamin D),
compared with resistance training alone on skeletal muscle
size, strength or function in healthy older men with a higher
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protein intake (>1.2 g/kg BW/d) at baseline. Whilst exercise
significantly improved several muscle health outcomes—
strength, lean mass (LM), muscle cross sectional area
(CSA), and gait speed—compared with the no exercise
group, no additional beneficial effects of milk beyond the
effect of exercise were observed. Specifically, the gains in
total body LM and mid-femur muscle CSA were two- to
threefold greater in the exercise + fortified milk group
compared with either group alone or the control group, but
the interaction terms were not significant for any muscle or
functional outcome after 18 months. The main effect ana-
lyses revealed that exercise significantly improved muscle
strength (~20–52%, p<0.001), LM (0.6 kg, p<0.05), muscle
CSA (1.8%, p<0.001), and gait speed (11%, p<0.05) com-
pared with the no exercise group. Moreover, the fortified
milk had no effect on muscle size, strength, or function.
Similar findings were noted in a study involving older
adults living in a residential care facility with poor nutritional
status and limitations in activities of daily living.
Improvements in balance, gait speed and lower-limb strength
were driven by a three-month high-intensity functional exer-
cise program with no additional benefits from combining
exercise with a milk-based protein supplement.69
Specifically, there was a significant improvement in gait
speed in the exercise compared with the control group (mean
difference 0.04 m/s, p=0.02) at three months, and significant
improvements in balance (Berg Balance Scale, 1.9 points,
p=0.05), gait speed (0.05 m/s, p=0.009), and lower-limb
strength (10.8 kg, p=0.03) after six months follow-up.
However, no interaction effects were observed between the
exercise and nutrition interventions (ie, milk-based protein-
enriched energy supplement). This could be partially explained
by the additional protein being oxidized to generate energy to
compensate for a negative energy balance in malnourished
older women.69 In another study involving residential care
residents with severe physical and cognitive impairment, no
change in intracellular water (ICW), a proxy for muscle mass,
was observed following a three-month intervention involving
an exercise program and milk-based protein enriched drink
providing ~15 g of protein after exercise.64 For example, the
between-group difference in ICW in exercise vs control activ-
ity group were not significant (mean 95% CI: −0.2
(−0.7 to 0.3), p=0.37), and no differences were observed
between the protein drink vs placebo drink group (−0.2
(−0.7 to 0.3), p=0.53). In both studies all participants were
assessed to be at risk of malnutrition (the Mini Nutritional
Assessment score <24), which may have explained negative
findings for muscle anabolism. Osuka et al68 compared the
effect of a combination of aerobic and resistance training
(ART) followed by consumption of fortified milk (10.5 g of
protein) against RT with fortified milk on muscle mass,
strength and function in healthy community-dwelling older
adults after 12 weeks of intervention. No between-group dif-
ferences in muscle mass were reported, but SMI, whole-body
muscle mass, upper-extremity muscle mass were increased in
the RTwith the fortified milk group, whereas lower-extremity
muscle mass was increased in both groups. Muscle strength
(leg extension strength, leg curl, leg press, chest press, arm
curl) and the time to complete chair stands also improved in
both groups, with the ART + fortified milk group improving
significantlymore comparedwith theRT+ fortifiedmilk group
(9.0±5.5 vs 5.3±3.8, p=0.005 arm curls per 30 s, and 5.9±3.9
vs 3.2±4.1, =0.01 chair rises per 30 s). In both intervention
groups protein intake was >1.3 g/kg BW/d at baseline. Lack of
a comparator group limits the interpretation of the study find-
ings, to addresswhether fortifiedmilk provided any benefits on
muscle health outcomes.
Two studies66,67 have evaluated the use of a chocolate
milk-based drink, with Maltais et al66 comparing EAA sup-
plement (12 g of protein, 7 g of EAA from soy) against milk
supplement (13.5 g of protein, 7 g of EAA) and nonprotein
control (rice milk) in older men with low muscle mass index
(MMI, muscle mass/high). All groups completed a 4-month
resistance training program three times a week. All partici-
pants improved significantly in several parameters of muscle
mass (ie, lean body mass, MMI and total muscle mass) and
muscle strength (lateral pull down 1-RM), but no between-
group differences were observed. For example, all groups
experienced significant change in MMI (control group: 0.52
(0.32) kg/m2; EAA group: 0.95 (0.55) kg/m2, and milk
group: 0.65 (0.47) kg/m2, p for all ≤0.05). For physical
capacity, only the EAA group improved in the TUG test.
The study had only 8–10 participants per group and all had
protein intake >0.8 g/kg BW/d. The authors concluded that
RE was an effective way of improving muscle mass and
strength regardless of protein supplementation. Conversely,
a study that compared the effect of 500 mL non-supplemen-
ted chocolate milk (14 g of protein/day) with RE to placebo
drink (0.4 g of protein) with RE in healthy young and old
men after 12 weeks of intervention, found that milk did not
enhance effects on skeletal muscle strength or hypertrophy
following resistance training. Although a strong training
effect was observed for all muscle strength measures (eg, 1-
RM for leg press, leg extension, and chest press in kg;
p<0.005), there was no significant interactive effect of
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chocolate milk supplementation (p >0.3).67 Protein intake
pre-intervention was not reported.
In summary, several intervention studies have investi-
gated how milk as a vehicle for protein and other nutrients
may enhance the beneficial effect of resistance training on
muscle mass, strength and function in older adults with
and without functional impairments. Collectively, current
evidence does not indicate any additional beneficial effects
of milk supplementation beyond the positive effects of RE
alone.
Discussion
Milk for Muscle Health: Summary of
Evidence and Implications
Milk is a complex food constituted of nutrients and biolo-
gically active components with anabolic, anti-oxidative,
anti-inflammatory, and immunomodulatory properties,
which as a part of a balanced diet may provide myoprotec-
tion for aging muscle. However, there is limited evidence
and current epidemiological and experimental research
does not provide support for additional benefits of (unfor-
tified or fortified) milk for muscle health and physical
performance in older adults. Evidence from one observa-
tional study suggests that higher childhood intake of whole
milk may have a beneficial effect on physical performance
and balance in later life.60 The associations between higher
adult intake of milk and muscle health were inconclusive
and based on only two studies, warranting further
research.60,61 Positive results observed for childhood
milk intake and muscle function in later life need to be
repeated in other populations.
In intervention studies (Table 2), (fortified) milk, alone
or in the combination with resistance training, provided no
benefits for muscle health. Specifically, two interventions
with fortified milk showed no evidence for an independent
effect of milk consumption on muscle strength and physi-
cal performance either in care residents62 or community-
dwelling older adults.63 Although very limited, the results
suggest that milk supplementation providing extra energy
and protein above habitual consumption may not be effec-
tive or sufficient to improve muscle function in older
adults with either higher dietary protein intake (ie, >0.8 g
of protein/kg BW/d in both studies) or functional limita-
tions. Of six intervention studies that combined exercise
with (fortified) milk supplementation, five found the main
effect of exercise on several parameters of muscle mass
and function,65–69 but no interaction effect of the exercise
and nutrition intervention in ether healthy community-
dwelling older adults or in those residing in care homes.
One study in care residents with functional impairments
found no exercise or interaction effect on muscle mass,64
which could be explained by malnutrition and negative
protein energy for muscle anabolism, multimorbidity, and
inadequate intervention duration for this population to
observe significant change.
Promising evidence for an interaction effect of milk and
exercise has been observed in several intervention studies with
younger adults and athletes, both men and women.19,43-45
A positive effect of (unfortified) milk immediately after exer-
cise has been reported for lean muscle mass, strength, MPS,
and loss of fat mass compared with control (isocaloric) or soy-
based drink,19,43-45 which the authors have contributed to the
following mechanisms. Compared to other protein sources,
milk proteins (especially whey) have greater ability to promote
anabolism postexercise, resulting in leanmuscle gain.19,45,48,59
Decreases in fat mass have been explained by the interplay
between parathyroid hormone, vitamin D metabolites, med-
ium-chain fatty acids, bioactive peptides and serum calcium
affecting cellular lipolysis (adipocytes lipid metabolism) and
fatty acids absorption, thus resulting in loss of fat mass (dis-
cussed in Dougkas et al).70
However, the results from interventions studies com-
bining fortified milk with exercise in older adults were
inconclusive, and several limitations of the studies have
been recognized by the authors. These include: (1) sample
size and lack of power to detect change in muscle health
outcomes affecting the validity of the study in the popula-
tion of interest;63–67 (2) lack of control group for proper
comparison;62,65 (3) insufficient study duration to observe
an effect in the population under study;62–64 (4) low milk
(protein) dose to induce muscle fiber hypertrophy in older
adults experiencing anabolic resistance;66,67,69 (5) attrition
and low compliance with the intervention;63 (6) a small
treatment effect, suggesting low clinical importance of
(fortified) milk in the study population;63,69 (7) selection
bias toward healthy older adults;65,68 (8) low generaliz-
ability to older adult population;65,68 (8) no blinding of
participants and assessors to the intervention;68,69 (9) lack
of mechanistic studies;62,63,68 and (10) the timing of the
nutrition intervention missing the “window of anabolic
opportunity” (ie, the timing of the protein feeding exceed-
ing 24 hours).65
Regardless of the differences across the studies (ie, parti-
cipants, sample size, intervention type, duration, intensity,
and muscle health outcomes), the results confirmed the
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effectiveness of resistance training for better muscle aging in
healthy and older adults with sarcopenia.71,72 Importantly,
the lack of the interaction effect between exercise and nutri-
tion (milk) in all studies calls for a careful consideration of
several factors that may have contributed to the null findings
when designing future studies using a whole food approach
(milk). These factors include: (1) nutrient (protein) dose in
milk; (2) timing of milk (protein) consumption; (3) habitual
protein intake; (4) insufficient understanding of the role of
other nutrients in milk for MPS; and (5) difficulties recruiting
older adults at risk of sarcopenia, who would likely benefit
the most from these interventions.73,74
Milk for Muscle Health: Possible Reasons
for Lack of Beneficial Effects in Studies
with Older Adults
Provision of sufficient protein (ie, dose) within milk repre-
sents a key consideration, particularly for older adults who
may exhibit anabolic resistance compared with younger
adults.30 Previous work has suggested that >20 g of pro-
tein per meal may be necessary to stimulate MPS in older
adults,11–13,22,48 yet all RCTs combining milk supplemen-
tation and exercise64–69 (Table 2) have provided amounts
below 20 g of protein/day either after exercise or every
day during the study period. The two studies with milk
supplementation intervention without exercise62,63 pro-
vided >33 g of protein/day, but the absence of RE, a potent
stimulus of MPS, may explain the negative results. A
recent meta-analysis has indicated that there is no evidence
to suggest that protein or EAA supplementation without
concomitant exercise interventions increases muscle mass
or strength in predominantly healthy older adults.75
However, a meta-analysis with meta-regression of 49 stu-
dies in healthy adults has shown that the effect of protein
supplementation in augmenting RE-induced change in fat-
free mass was effective in young adults (<40 years) and
less effective with advancing age (>40 years), but ineffec-
tive beyond total protein intake of ~1.6 g/kg BW/day.76
This suggests that the protein dosage and the total protein
intake may be the possible reasons for the negative results
in the studies.
One challenge in collating this evidence is that the
frequency of milk dose varied between the studies; three
RCTs have provided nutritional supplement daily65,67,68
and three on the training days only,63,66,69 which makes
the comparison between the studies challenging.
Adherence to (fortified) milk drinking was >80% across
the studies, suggesting that milk drinking was feasible for
older adults. However, a greater amount of milk is needed
to provide a dose >20 g of protein, which needs to be
assessed in this population.77
An important consideration for maximizing potential
adaptation is the timing of protein consumption. For exam-
ple, a study involving older men has shown that ingestion of
protein supplement (10 g protein) immediately postexercise
(within five minutes) stimulated greater skeletal muscle
hypertrophy compared with the ingestion two hours post-
training.78 However, a study comparing the effect of protein
supplementation pre- and post-RE between young (≤40
years) and older men (≥59 years) has found no effect of
supplementation on muscle mass and strength in older
adults.79 This suggests that the dosages of protein may be
more important than timing. The timing of the milk intake
in the RCTs with exercise component described in this
review varied from five minutes after exercise,64,69 imme-
diately after exercise66–68 to non-specific,65 the latter study
possibly missing the “MPS window” post-RE stimulus for
beneficial effect.
A key issue is the role of other nutrients present in milk,
especially fats, which are rarely considered; the composi-
tional differences in milk across the studies for MPS stimu-
lation postexercise in older adults is unknown. There is
some evidence that fat content may be important, as in a
study of healthy young volunteers, Elliott et al59 demon-
strated that milk ingestion-stimulated net MPS following
RE was more effective in the whole milk than in fat-free
milk group—a difference that was explained by higher net
amino acid uptake, hypothesized to be related to a higher fat
content in whole milk. However, compositional difference
in milk across the reviewed studies (eg, supplemented with
protein,63,64,66,68,69 vitamin D and Ca,62,65 EAA,66
chocolate;66,67 reduced or low fat (≤1.6%) in seven out of
eight studies) makes the synthesis of their findings difficult,
and the implications for future trials of milk supplementa-
tion challenging.
Another important point to consider relates to partici-
pants’ habitual dietary protein intake in these studies. In all
the studies of older independent adults for whom there
were baseline dietary data (Table 2), habitual protein
intakes were above the recommended intakes (0.8 g/kg
BW/d), reaching 1.2–1.3 g/kg BW/d in two studies.65,68
Thus increased protein/milk consumption provided
through the intervention was in populations that already
consumed adequate amounts of protein for muscle health,
and therefore unlikely to have a substantial additional
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effect on muscle outcomes. For example, in a study of
healthy older men and women with adequate habitual
protein intake, protein supplementation of 15 g/day after
a prolonged resistance-type exercise program did not aug-
ment beneficial effect of exercise on muscle mass, strength
and function.80 Similarly, in a recent RCT, the Liverpool
Hope University—Sarcopenia Aging Trial, supplementa-
tion with a leucine-enriched whey protein isolate (1.5 g/kg
BW/d) after resistance and functional exercise program
did not provide any additional benefit in healthy older
adults who already consumed sufficient amounts of dietary
protein at study enrollment.81 Interestingly, the authors
suggest that future trials should use whole protein-contain-
ing foods instead of supplements because of low compli-
ance (43±14%) to dietary-protein supplementation in this
trial, which may have contributed to the null results.81
A big challenge to date for RCTs is the recruitment of
older adults with sarcopenia, who may respond differently
to the milk supplementation after RE treatment compared
with those with lesser degrees of muscle dysfunction. In the
present review only two trials included pre-sarcopenic older
adults;63,66 further research should determine whether those
with different levels of skeletal muscle dysfunction respond
differently to interventions.
Another challenge to consider in milk-based interventions
with older adults relates to a substantial variation in milk
consumption across the world regions,33 explained in part by
affordability and environmental concerns related to animal-
based protein production and consumption,22,23 and the pre-
sence of lactose intolerance (LI) and malabsorption in the
populations.82 Although much LI is genetically predetermined
(ie, lactase nonpersistence, LNP), self-reported LI has been
estimated at a greater prevalence then LNP in a number of
studies, with links to female gender, advanced age, race, body
size, dose of lactose, and genetic differences in LNP.83,84 Also,
the malabsorption of nutrients and gastrointestinal symptoms
should be considered when designing nutritional interventions
with whole foods, including milk and dairy in older adults.
Nutrient absorption in older adults can be compromised by
nutrient-drug interaction, atrophic gastritis leading to hypo-
chlorhydria and altered acid-pepsin digestion, resulting in
impaired absorption of vitamins and minerals, such as folate,
vitamin B12, calcium, iron and β-carotene (discussed in
Granic et al).85 In a study of 400 Finnish adults (aged 18–64
years), only milk protein IgG, not IgA antibodies were asso-
ciated with self-perceived gastrointestinal symptoms, which
have been suspected to be caused by milk indigestion in over
40% of adults in primary care.86
In summary, synthesizing findings from existing interven-
tion studies (Table 2) presents a challenge because of differ-
ences in study design (eg, sample size, study arms),
participants (eg, baseline fitness, habitual protein intake, sarco-
penia status, setting) and intervention characteristics (eg, exer-
cise training program, protein supplementation protocol,
adherence/compliance to intervention). Current evidence
does not show benefit of milk supplementation of older adults
for muscle health. However, inadequate dose of protein (via
milk), high habitual protein intakes, fitness and sarcopenia
status at baseline may be among the main reasons for the
lack of demonstrated effects of milk.
Milk for Muscle Health: Areas for Future
Aging Research
There is relatively little evidence about the role of milk in
muscle health and functioning and sarcopenia in older adults
fromboth observational and intervention studies. Awhole food
approach in testing the nutrition–muscle health hypothesis
emphasizes nutrient-dense foods that are affordable, sustain-
able, easy to prepare, and palatable to older adults. Liquidmilk
may be such a food because it contains nutrients and other
bioactive components that have multiple myoprotective prop-
erties, which may act against several pathogenic pathways
implicated in sarcopenia, including inflammation and oxida-
tive stress. However, there are several obstacles facing obser-
vational and intervention research of muscle aging in reaching
a higher level of evidence about the role of whole foods (milk)
in treatment and prevention of sarcopenia. These include: (1)
the type and amount of milk (eg, low-fat vs whole; readily
available vs fortified); (2) the type, frequency and intensity of
exercise intervention (resistance training vs resistance and
functional training); (3) the harmonization of the operational
definition of sarcopenia1,3 and muscle-related outcomes; (4)
determination of target population (eg, sarcopenic vs at-risk
population living in the community and residential care); (5)
the timing of follow-up or intervention (weeks vsmonths); and
(6) life stages (eg, a life course approach; mid vs late adult-
hood). Adequately powered RCTs of well characterized older
adults likely to benefit from the interventions using a whole
food approach are needed to test their effectiveness for healthy
muscle ageing. In addition, milk may not be an appropriate
functional food formitigating loss ofmusclemass and function
for all older adults. For example, although higher milk and
dairy intake has been associated with other positive health
outcomes,34–43,47 lactose intolerance should be considered
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when designing RCTs with older adults with multimorbidities
(eg, diabetes, obesity) and milk allergies.82–84
Conclusions
Milk contains biologically active nutrients and components
that have anabolic, anti-inflammatory, anti-oxidative, and
immunomodulating properties, and thus may be myoprotec-
tive. However, there is currently relatively little evidence
from both observational and intervention studies with older
adults about the benefits of milk as a functional food for
muscle health. A limited number of studies summarized in
this review included older adults that were mostly healthy,
well-functioning, and well-nourished (ie, good protein
intake), and varied greatly in the type, amount and timing
of milk intake, length of intervention, and sarcopenia status.
Sufficiently powered intervention studies in well character-
ized groups of older adults most likely to benefit from inter-
ventions are needed to test the effectiveness of a whole food
approach, including milk, for healthy muscle aging.
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